Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cardiotoxicity × Proteins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 2 Neoplasms 1 Malnutrition 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Doxorubicin 13 Exercise 8 Dexrazoxane 7 Cyclophosphamide 7 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Echocardiography 3 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Trastuzumab 2 Tablets 2 Prednisone 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Electrocardiography 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Bleomycin 2 Bisoprolol 2 sulforaphane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06622954 2024-10-02

PROTECT-COR

Erasmus Medical Center

Phase NA Recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡